IL-10 measurement in aqueous humor for screening patients with suspicion of primary intraocular lymphoma

被引:156
|
作者
Cassoux, Nathalie
Giron, Alain
Bodaghi, Bahram
Tran, Thi H. C.
Baudet, Sylvie
Davy, Frederic
Chan, Chi C.
Lehoang, Phuc
Merle-Beral, Helene
机构
[1] Hop La Pitie Salpetriere, Dept Ophthalmol, F-75013 Paris, France
[2] Hop La Pitie Salpetriere, Dept Hematol, F-75013 Paris, France
[3] INSERM, Unite 678, F-75730 Paris, France
[4] NEI, Immunol Lab, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1167/iovs.06-0031
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE. To determine the value of IL-10 measurement in aqueous humor (AH) for screening in primary intraocular lymphoma (PIOL). METHODS. One hundred consecutive diagnostic or therapeutic vitrectomies were performed in patients with uveitis. During surgery, 100 mu L of both AH and pure vitreous was taken. IL-10 levels were determined with a standard quantitative sandwich enzyme immunoassay technique. Patients were distributed in two groups: 51 patients with proven PIOL, 108 patients with uveitis divided into 74 with uveitis of proven etiology and 34 with idiopathic uveitis. Groups were compared by ANOVA and the Tukey-Kramer test or nonparametric Wilcoxon test. Distributions were compared by using the chi(2) test. Segmentation was derived from the ROC curves by choosing a tradeoff between sensitivity and specificity. RESULTS. In patients with PIOL, IL-10 mean values were 2205.5 pg/mL (median: 1467 pg/mL) in the vitreous and 543.4 pg/mL (median: 424 pg/mL) in AH. In patients with uveitis (idiopathic and diagnostic uveitis), mean values were 26.6 pg/ mL ( median: 8 pg/mL) in the vitreous, and 21.9 pg/mL (median: 8 pg/mL) in AH. IL-10 mean values were significantly different between patients with PIOL and patients with uveitis (P < 10(-3)). The areas under the curves were 0.989 and 0.962 for vitreous and AH, respectively. A cutoff of 50 pg/ mL in the AH was associated with a sensitivity of 0.89 and a specificity of 0.93. In the vitreous, a cutoff value of 400 pg/ mL yielded a specificity of 0.99 and a sensitivity of 0.8. CONCLUSIONS. Diagnosis of PIOL is often made months or years after the initial onset of ocular symptoms. Cytology remains the gold standard for diagnosis. However, measurement of IL-10 in the AH is a good screening test to reduce diagnostic delays.
引用
收藏
页码:3253 / 3259
页数:7
相关论文
共 50 条
  • [41] Effects of travoprost on aqueous humor dynamics in patients with elevated intraocular pressure
    Toris, Carol B.
    Zhan, Guilin
    Fan, Shan
    Dickerson, Jaime E.
    Landry, Theresa A.
    Bergamini, Michael V. W.
    Camras, Carl B.
    JOURNAL OF GLAUCOMA, 2007, 16 (02) : 189 - 195
  • [42] Whole blood production of interleukin-10 (IL-10) and IL-10 plasma levels in ESRD patients.
    Lonnemann, G
    Eberhard, O
    Linnenweber, S
    Koch, KM
    Dinarello, CA
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A1207 - A1207
  • [43] Dysregulated expression of microRNAs in aqueous humor from intraocular tuberculosis patients
    Chadalawada, Swathi
    Kathirvel, Kandasamy
    Lalitha, Prajna
    Rathinam, S. R.
    Devarajan, Bharanidharan
    MOLECULAR BIOLOGY REPORTS, 2022, 49 (01) : 97 - 107
  • [44] Dysregulated Expression of microRNAs in Aqueous Humor from Intraocular Tuberculosis Patients
    Devarajan, Bharanidharan
    Chadalawada, Swathi
    Kandasamy, Kathirvel
    Prajna, Lalitha
    Rathinam, S. R.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
  • [45] Interleukin-10 (IL-10) 1082 promoter polymorphisms and plasma IL-10 levels in patients with bacterial sepsis
    Vivas, Monica Chavez
    Villamarin-Guerrero, Hector Fabio
    Sanchez, Carlos Alberto
    ROMANIAN JOURNAL OF INTERNAL MEDICINE, 2021, 59 (01) : 50 - 57
  • [46] Serum IL-10 is associated with neurologic symptoms and interference in primary brain tumor patients
    Slattery, Kaitlynn A.
    Wright, Michelle L.
    Raval, Dhaivat
    Hsieh, Emory
    Kauss, McKenzie C.
    Armstrong, Terri S.
    Mendoza, Tito R.
    Guedes, Vivian A.
    CANCER RESEARCH, 2024, 84 (06)
  • [47] Screening of Reducing Agents for the PEGylation of Recombinant Human IL-10
    Alexandre Ambrogelly
    Collette Cutler
    Brittany Paporello
    The Protein Journal, 2013, 32 : 337 - 342
  • [48] Expression of IL-10 in patients with ovarian carcinoma
    Mustea, A
    Könsgen, D
    Braicu, EI
    Pirvulescu, C
    Sun, PM
    Sofroni, D
    Lichtenegger, W
    Sehouli, J
    ANTICANCER RESEARCH, 2006, 26 (2C) : 1715 - 1718
  • [49] Screening of Reducing Agents for the PEGylation of Recombinant Human IL-10
    Ambrogelly, Alexandre
    Cutler, Collette
    Paporello, Brittany
    PROTEIN JOURNAL, 2013, 32 (05): : 337 - 342
  • [50] Mantle cell lymphoma proliferation upon CD40 stimulation: Role of IL-10 and IL-10 receptor expression.
    Visser, HPJ
    Tewis, M
    Willemze, R
    Kluin-Neleman, JC
    BLOOD, 1998, 92 (10) : 405A - 405A